Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.
about
Applications of targeted proteomics in systems biology and translational medicineInsights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMicrowave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodiesAnalytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometryThyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.First Steps toward Harmonization of LC-MS/MS Thyroglobulin AssaysClinical review: improving the measurement of serum thyroglobulin with mass spectrometry.Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysSerum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake.Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.LC-MS/MS in the routine clinical laboratory: has its time come?Quantitation of human peptides and proteins via MS: review of analytically validated assays.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges.Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry.Important options available--from start to finish--for translating proteomics results to clinical chemistry.Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays.Cancer proteomics: developments in technology, clinical use and commercialization.Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study.Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.Clinical applications of MS-based protein quantification.Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization.Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods.Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays.Development of Standard Reference Materials to support assessment of iodine status for nutritional and public health purposes.Progress in standardizing and harmonizing thyroid function tests.A combined tryptic peptide and winged peptide internal standard approach for the determination of α-lactalbumin in dairy products by ultra high performance liquid chromatography with tandem mass spectrometry.Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.Assessment of the influence of the patient's inflammatory state on the accuracy of a haptoglobin selected reaction monitoring assay.Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma.Serum thyroglobulin in the monitoring of differentiated thyroid cancer.Multiplexed longitudinal measurement of protein biomarkers in DBS using an automated SISCAPA workflow.Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.
P2860
Q26852271-62B58C13-218F-4DCC-A099-77B640DC2889Q28078289-D4BDAB3D-8607-43E4-9B35-75E61B9C9D35Q30367068-05FE7975-A337-4CBF-A4C9-0256B7C3CC6EQ34124465-7104FA12-3463-4BA9-97CA-C9CD7D7B115BQ34134307-8576972A-02CD-4538-BC1C-41B5F72B8854Q34669490-53AB7196-A5EF-43F5-B119-E4D0D223D3F8Q35044673-142EC7E7-662B-45FD-A00D-9C60753211EEQ35916507-FE542B06-AFFD-493D-9EFF-CD05C2FB52D1Q36134039-47DA719D-1E44-43EC-AA42-EDE1FAA779F3Q36693015-AFA0729A-2A76-4188-BF2F-CA6A691CB5A2Q36736452-AA53DAA1-223D-4560-AA6B-6D582BEE3609Q36794987-27B060A4-C3E3-4B18-AB64-6BEA4A00CD3AQ37467949-DC44F9D0-8B07-4218-B2F2-69CE7C60B776Q37623655-E88B028E-8A9A-42BF-A1A8-6E7EE0E97D3FQ37736235-664A12D2-4490-4ADE-8F4E-35583E13793CQ38171274-C9FA0D91-8DC4-44BA-ADA7-3B3C0B40D072Q38243345-DBC8CC46-DFF1-432D-983C-FB80DC8872CCQ38260022-4165AE50-FA5A-4814-A129-597B440F9E5AQ38263758-15C35249-21A7-41CD-87AB-635F1EF0CD3EQ38270732-B42A1DEF-EA39-47A9-A297-6932AE37E1ABQ38282797-7855025E-12BC-404D-A3B7-A63EB9470E29Q38500988-07EE94E4-8A9C-4E3F-ABC2-5274ADBFB420Q38543009-913E37EE-2E52-4F65-B42A-C83E7367C3D1Q38628086-BFC0C7A9-4DBA-40F8-8849-3F2A9169329BQ38716870-C133DA9B-F201-43E2-9158-EF6A0C449167Q38802991-6F4D8E02-F2C8-4C23-A6AC-CBCAB5ACFD22Q38812885-A8FA7B1D-9074-4389-8E89-25EF0ECD6BBDQ38844250-815484AA-D2C0-4F8A-A637-B2A6424B3DCAQ39231107-671ABAB0-2808-4BB3-B05B-108379FBA6E3Q40733332-2A78616F-B4E1-4CBB-8056-55EFB5D4EAECQ40973355-CE20ED9E-213E-4AB3-A2CD-A77DD1829615Q40973408-32789665-270E-4A4A-A75A-1A1AE5A5601BQ41259033-9A7ECB18-A3FF-4390-A80A-54506CC83B3DQ41772758-0257002D-C69E-4058-8FCF-3EEB8913254CQ42085201-4CE2CDC8-DD86-46B0-B2D5-ECEF00EB933EQ50056831-471DCD95-477F-4023-8068-8B311CD238E3Q51505699-80800810-276E-4F02-B10B-85949C8E873BQ51561970-73D425EF-17E1-4BB9-8794-E4971632CDDDQ51639568-CDD6FA63-C203-46FA-8356-08216556C8E3Q52335444-E4C39FAB-6EA3-4EFC-93CB-7EE3882FB416
P2860
Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@ast
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@en
type
label
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@ast
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@en
prefLabel
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@ast
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@en
P2093
P2860
P1433
P1476
Measurement of thyroglobulin b ...... ithyroglobulin autoantibodies.
@en
P2093
A Wayne Meikle
Alan L Rockwood
Dev Abraham
Mark M Kushnir
William L Roberts
P2860
P304
P356
10.1373/CLINCHEM.2012.195594
P407
P577
2013-02-08T00:00:00Z